Login
Users of this system, can login to view this document.
Enter the following information to request a copy of the document from the responsible person.
Bharangin, a Diterpenoid Quinonemethide, abolishes constitutive and inducible nuclear factor-kappa B (NF-kappa B) activation by modifying p65 on Cysteine 38 residue and reducing inhibitor of nuclear factor-kappa B alpha Kinase activation, leading to suppression of NF-kappa B-regulated gene expression and sensitization of tumor cells to chemotherapeutic agents